You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

5-HT7 receptor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Implication of 5-HT7 Receptor in Inflammatory Mechanisms in

Not yet recruiting
  • Healthy
  • Multiple Sclerosis
  • Blood sample
  • Orléans, France
    CHR Orléans
Feb 16, 2023

5-HT7 Receptor Implication in Inflammatory Mechanisms in

Completed
  • Multiple Sclerosis, Acute Relapsing
  • Multiple Sclerosis
  • blood sampling
  • Orléans, France
    CHR Orléans
Feb 16, 2022

Acute Respiratory Distress Syndrome Trial in Montréal (Placebo, Ondansetron Injection)

Not yet recruiting
  • Acute Respiratory Distress Syndrome
  • Placebo
  • Ondansetron Injection
  • Montréal, Quebec, Canada
    Hôpital Sacré-Coeur de Montréal
Aug 22, 2022

Breast Cancer, Chemo-induced Nausea and Vomiting Trial in Hanzhou (Aprepitant, Palonosetron, Fosaprepitant)

Not yet recruiting
  • Breast Cancer
  • Chemotherapy-induced Nausea and Vomiting
  • Hanzhou, Zhejiang, China
    the Second Affiliated Hospital of Zhejiang Univercity School of
Apr 23, 2023

Parkinson Disease Trial in Bron, Lyon (neuropsychological assessment, biological sample, medical imagery)

Not yet recruiting
  • Parkinson Disease
  • neuropsychological assessment
  • +2 more
  • Bron, France
  • +1 more
Jun 13, 2023

Pediatric Cancer Trial in Yerevan (Ondansetron, Dexamethasone)

Not yet recruiting
  • Pediatric Cancer
  • Yerevan, Armenia
    Hematology Center named after prof. R. Yeolyan
May 23, 2023

Acneiform Eruption Due to Chemical, Xerosis Cutis, Paronychia Trial (HT-001 2% Topical Gel, HT-001 1% Topical Gel, HT-001 0.5%

Not yet recruiting
  • Acneiform Eruption Due to Chemical
  • +2 more
  • HT-001 2% Topical Gel
  • +3 more
  • (no location specified)
Dec 3, 2022

LARS - Low Anterior Resection Syndrome Trial in Seoul (Ramosetron)

Not yet recruiting
  • LARS - Low Anterior Resection Syndrome
  • Seoul, Jongro-gu, Korea, Republic of
    Seoul National University Hospital
Dec 13, 2022

Adverse Effect Trial (normal saline, Ondansetron 4 mg, Ondansetron 8 mg)

Not yet recruiting
  • Adverse Effect
  • normal saline
  • +2 more
  • (no location specified)
Jul 25, 2022

Healthy Trial in Basel (Placebo, Mescaline 100mg, Mescaline 200mg)

Recruiting
  • Healthy
  • Placebo
  • +5 more
  • Basel, BS, Switzerland
    University Hospital Basel, Clinical Trial Unit
Aug 17, 2021

Bipolar Disorder Trial in London (JNJ-18038683, Placebo)

Recruiting
  • Bipolar Disorder
  • London, United Kingdom
    King's College London
Sep 6, 2021

Exploration of Cluster Headache in a PET-MRI Study

Not yet recruiting
  • Cluster Headache, Episodic
  • PET-MRI in pain-free remission period
  • (no location specified)
Oct 18, 2021

Bipolar Disorder Trial in Chicago (JNJ-18038683)

Active, not recruiting
  • Bipolar Disorder
  • Chicago, Illinois
    Mahdi Arshadi
Jan 18, 2022

Breast Cancer, Breast Tumor Trial in Philadelphia ([18F]ISO-1)

Active, not recruiting
  • Breast Cancer
  • Breast Neoplasm
  • Philadelphia, Pennsylvania
    University of Pennsylvania Hospital
Jan 17, 2023

Depressive Symptoms, Depression, Alzheimer Trial in Baltimore (Psilocybin)

Recruiting
  • Depressive Symptoms
  • +3 more
  • Baltimore, Maryland
    Behavioral Pharmacology Research Unit
Mar 9, 2022

Motility Disorder of Intestine, Ondansetron, Small Bowel Water Trial in Nottingham (Ondansetron 8mg, abdominal MRI, Lactulose)

Completed
  • Motility Disorder of Intestine
  • +2 more
  • Ondansetron 8mg
  • +3 more
  • Nottingham, Nottinghamshire, United Kingdom
    University of Nottingham
Nov 26, 2019

Breast Cancer Trial in Poland, United States (ZN-c5, Abemaciclib)

Recruiting
  • Breast Cancer
  • Gilbert, Arizona
  • +6 more
Feb 14, 2022

Metastatic Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7 Trial in United States (drug, other, biological)

Suspended
  • Metastatic Breast Carcinoma
  • Stage IV Breast Cancer AJCC v6 and v7
  • Corona, California
  • +6 more
Sep 28, 2022

Pre-Eclampsia, Pregnancy Induced Hypertension, Pregnancy Related Trial in Oxford (Arcofolin® 5-Methyltetrahydrofolate,

Recruiting
  • Pre-Eclampsia
  • +2 more
  • Arcofolin® 5-Methyltetrahydrofolate
  • Arcofolin® Placebo
  • Oxford, Oxfordhsire, United Kingdom
  • +1 more
Jun 22, 2022

CAR T-Cell Therapy Trial in Shenzhen (HEC-016(0.5×10^6 CAR-T Cells), HEC-016(0.5×10^6.5 CAR-T Cells), HEC-016(0.5×10^7 CAR-T

Recruiting
  • CAR T-Cell Therapy
  • HEC-016(0.5×10^6 CAR-T Cells)
  • +2 more
  • Shenzhen, Guangdong, China
    Shenzhen Luohu Hospital
Mar 3, 2022

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Non-Small Cell Cancer AJCC v7

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +5 more
  • Laboratory Biomarker Analysis
  • +3 more
  • New Haven, Connecticut
  • +4 more
Jan 27, 2023

Breast Tumors Trial in Japan (E7090, Fulvestrant, Exemestane)

Recruiting
  • Breast Neoplasms
  • Nagoya, Aichi, Japan
  • +10 more
Nov 11, 2022

Guide Experimental Targeted Therapy - National

Recruiting
  • Cancer
    • Belfast, United Kingdom
    • +19 more
    Aug 23, 2022

    Focal Segmental Glomerulosclerosis Trial in Worldwide (sparsentan, Irbesartan)

    Active, not recruiting
    • Focal Segmental Glomerulosclerosis
    • Mesa, Arizona
    • +224 more
    Oct 27, 2022

    AREG, EREG and EGFR: Response to Anti-EGFR Agents in Colorectal

    Active, not recruiting
    • Colorectal Cancer Stage IV
    • Immunohistochemistry
    • Huddersfield, West Yorkshire, United Kingdom
    • +6 more
    Feb 22, 2022